Molecular correlates of response to eribulin and pembrolizumab in hormone receptor-positive metastatic breast cancer.

Nat Commun · 2021 · PMC8455578 · PMID 34548479

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

showed a trendno p-value reported

Additionally, ssGSEA showed a trend towards greater estrogen response gene set enrichment in NCB tumors (Fig. 5d ), although this was not statistically significant (Supplementary Fig. 9c, d ).

also in 53,322 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.